Is a complete CRSP research report available?

No complete published report is available for CRISPR Therapeutics AG (CRSP) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

CRISPR Therapeutics AG (CRSP)

NASDAQ: CRSP · USD

$54.1

+2.60 (+5.0%)· Recorded snapshot

Market cap	5.2B
Revenue (ttm)	13.4M
Net income (ttm)	-451.1M
EPS (ttm)	-$4.76
Shares out	96.7M
Volume	905,476
Beta	1.76

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 13.4M
Net income (ttm): -451.1M
EPS (ttm): -$4.76
Market cap: 5.2B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	持有

Metric	Value
Amount currency	USD
CIK code	0001674416
Company name	CRISPR Therapeutics AG
Country	Switzerland
Country code	US
CUSIP number	H17182108
Earnings date	2026-11-09
Earnings time	bmo
Employees	393
Employees change	-14
Employees growth	-3.44%
Enterprise value	$3.6B
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2013
In index	RUSSELL2000
Industry	Biotechnology
IPO date	2016-10-19
Is primary listing	Yes
Is SPAC	No
ISIN number	CH0334081137
Last 10-K release date	2026-02-12
Last earnings date	2026-08-03
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$5.2B
Market cap category	Mid-Cap
Next earnings date	2026-11-09
Options	Yes
Price	$54.07
Price currency	USD
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-28
Symbol	CRSP
Website	https://www.crisprtx.com

Metric

Value

Amount currency

USD

CIK code

0001674416

Company name

CRISPR Therapeutics AG

Country

Switzerland

Country code

CUSIP number

H17182108

Earnings date

2026-11-09

Earnings time

bmo

Employees

393

Employees change

-14

Employees growth

-3.44%

Enterprise value

$3.6B

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2013

In index

RUSSELL2000

Industry

Biotechnology

IPO date

2016-10-19

Is primary listing

Yes

Is SPAC

ISIN number

CH0334081137

Last 10-K release date

2026-02-12

Last earnings date

2026-08-03

Last refreshed

2026-10-28

Last stock split type

Never

Market cap

$5.2B

Market cap category

Mid-Cap

Next earnings date

2026-11-09

Options

Yes

Price

$54.07

Price currency

USD

Sector

Healthcare

SIC code

2836

Stock price date

2026-10-28

Symbol

CRSP

Website

https://www.crisprtx.com

Metric	Value
Earnings yield	-8.8%
EV/Sales	263.2x
FCF / EV yield	-10.53%
FCF yield	-7.27%
Forward EV/Sales	43.71x
Forward P/S	63.32x
P/B ratio	2.85x
P/S ratio	381.23x
Price / tangible book value	2.92x
Sector forward P/E	23.56x
Sector P/E	50.08x

Metric

Value

Earnings yield

-8.8%

EV/Sales

263.2x

FCF / EV yield

-10.53%

FCF yield

-7.27%

Forward EV/Sales

43.71x

Forward P/S

63.32x

P/B ratio

2.85x

P/S ratio

381.23x

Price / tangible book value

2.92x

Sector forward P/E

23.56x

Sector P/E

50.08x

Metric	Value
Operating margin	-3,971.53%
Pretax margin	-3,346.08%
Profit per employee	$-1.1M
Revenue per employee	$34,076
ROA	-14.2%
ROA (5Y)	-8.33%
ROCE	-21.12%
ROE	-26.09%
ROE (5Y)	-13.88%
ROIC	-325.94%
ROIC (5Y)	-91.82%
SBC / revenue	510.16%
Tax / revenue	22.64%

Metric

Value

Operating margin

-3,971.53%

Pretax margin

-3,346.08%

Profit per employee

$-1.1M

Revenue per employee

$34,076

ROA

-14.2%

ROA (5Y)

-8.33%

ROCE

-21.12%

ROE

-26.09%

ROE (5Y)

-13.88%

ROIC

-325.94%

ROIC (5Y)

-91.82%

SBC / revenue

510.16%

Tax / revenue

22.64%

Metric	Value
EPS growth quarters	2
EPS growth years	0
Net income growth quarters	2
Net income growth years	0
Revenue growth	-64.8%
Revenue growth (Q)	1,041.37%
Revenue growth (QoQ)	598.29%
Revenue growth 10Y	24.32%
Revenue growth 3Y	-57.14%
Revenue growth 5Y	-56.91%
Revenue growth quarters	2
Revenue growth years	0

Metric

Value

EPS growth quarters

EPS growth years

Net income growth quarters

Net income growth years

Revenue growth

-64.8%

Revenue growth (Q)

1,041.37%

Revenue growth (QoQ)

598.29%

Revenue growth 10Y

24.32%

Revenue growth 3Y

-57.14%

Revenue growth 5Y

-56.91%

Revenue growth quarters

Revenue growth years

Metric	Value
Capital expenditures	$-1.7M
Depreciation and amortization	$18.7M
EBIT	$-531.9M
EBITDA	$-513.2M
EPS	$-4.76
FCF per share	$-3.84
Financing cash flow	$1B
Free cash flow	$-371.3M
Free cash flow minus SBC	$-439.6M
Gross profit	$-461.8M
Income taxes	$3M
Investing cash flow	$-548.4M
Net borrowing	$600M
Net cash flow	$94.2M
Net income	$-451.1M
Operating cash flow minus SBC	$-437.9M
Operating income	$-531.9M
Revenue	$13.4M
Stock-based compensation	$68.3M

Metric

Value

Capital expenditures

$-1.7M

Depreciation and amortization

$18.7M

EBIT

$-531.9M

EBITDA

$-513.2M

EPS

$-4.76

FCF per share

$-3.84

Financing cash flow

$1B

Free cash flow

$-371.3M

Free cash flow minus SBC

$-439.6M

Gross profit

$-461.8M

Income taxes

$3M

Investing cash flow

$-548.4M

Net borrowing

$600M

Net cash flow

$94.2M

Net income

$-451.1M

Operating cash flow minus SBC

$-437.9M

Operating income

$-531.9M

Revenue

$13.4M

Stock-based compensation

$68.3M

Metric	Value
Altman Z-Score	2.68
Book value per share	$18.07
Debt / equity	0.45
Long-term assets	$279M
Long-term liabilities	$771.3M
Net cash (debt)	$1.6B
Net cash / market cap	30.96%
Net cash growth	4.97%
Net debt / equity	-0.9
Piotroski F-Score	2
Property, plant and equipment	$233.7M
Shareholders' equity	$1.7B
Tangible book value	$1.7B
Tangible book value per share	$18.07
Total assets	$2.7B
Total cash	$2.4B
Total debt	$783.7M
Total liabilities	$904.2M
WACC	12.07%

Metric

Value

Altman Z-Score

2.68

Book value per share

$18.07

Debt / equity

0.45

Long-term assets

$279M

Long-term liabilities

$771.3M

Net cash (debt)

$1.6B

Net cash / market cap

30.96%

Net cash growth

4.97%

Net debt / equity

-0.9

Piotroski F-Score

Property, plant and equipment

$233.7M

Shareholders' equity

$1.7B

Tangible book value

$1.7B

Tangible book value per share

$18.07

Total assets

$2.7B

Total cash

$2.4B

Total debt

$783.7M

Total liabilities

$904.2M

WACC

12.07%

Metric	Value
Asset turnover	0.01
Current assets	$2.4B
Current liabilities	$132.9M
Current ratio	17.85
Net working capital	$-106.8M
Quick ratio	17.79
Working capital	$2.2B
Working capital turnover	0.01

Metric

Value

Asset turnover

0.01

Current assets

$2.4B

Current liabilities

$132.9M

Current ratio

17.85

Net working capital

$-106.8M

Quick ratio

17.79

Working capital

$2.2B

Working capital turnover

0.01

Metric	Value
Buyback yield / dilution	-10.33%
Dividend yield	0%
Shareholder yield	-10.33%

Metric

Value

Buyback yield / dilution

-10.33%

Dividend yield

Shareholder yield

-10.33%

Metric	Value
10Y price change	235.65%
10Y return CAGR	12.88%
10Y total return	235.65%
150-day SMA	$52.94
1D price change	5.05%
1M price change	-2.08%
1M total return	-2.08%
1W price change	6.46%
1W total return	6.46%
1Y price change	-19.2%
1Y return CAGR	-19.21%
1Y total return	-19.2%
20-day SMA	$51.72
200-day SMA	$52.91
3M price change	13.63%
3M total return	13.63%
3Y price change	37.07%
3Y return CAGR	11.08%
3Y total return	37.07%
50-day SMA	$54.41
50-day SMA vs 200-day SMA	50over200
52-week high	$65.98
52-week high date	2025-10-31
52-week low	$44.12
52-week low date	2026-03-30
5Y price change	-42.77%
5Y return CAGR	-10.56%
5Y total return	-42.77%
6M price change	4.14%
6M total return	4.14%
All-time high	$220.20
All-time high date	2021-01-15
All-time low	$11.63
All-time low date	2017-02-15
Average true range (ATR)	$2.54
Average volume	1.5M
Beta (1Y)	2.1
Beta (2Y)	1.84
Beta (5Y)	1.76
Change from 52-week high	-18.05%
Change from 52-week low	22.55%
Change from all-time high	-75.89%
Change from all-time low	356.58%
Change from open	7.15%
Day's gap	-1.96%
Dollar volume	$49M
High price	$54.11
Low price	$50.46
Monthly RSI	49.86
Open price	$50.46
Position in 52-week range	98.9%
Premarket change	-0.89%
Premarket close	$51.47
Premarket price	$51.01
Premarket volume	5.2K
Previous close	$51.47
Price vs 150-day SMA	0.3%
Price vs 20-day SMA	2.67%
Price vs 200-day SMA	0.35%
Price vs 50-day SMA	-2.41%
Relative volume	0.61
RSI	53.05
Sharpe ratio	-0.16
Sharpe ratio (3Y)	0.4
Sharpe ratio (5Y)	0.03
Sortino ratio	-0.13
Sortino ratio (3Y)	0.75
Sortino ratio (5Y)	0.14
Volume	905.5K
Weekly RSI	50.23
YTD price change	1.26%
YTD total return	1.26%

Metric

Value

10Y price change

235.65%

10Y return CAGR

12.88%

10Y total return

235.65%

150-day SMA

$52.94

1D price change

5.05%

1M price change

-2.08%

1M total return

-2.08%

1W price change

6.46%

1W total return

6.46%

1Y price change

-19.2%

1Y return CAGR

-19.21%

1Y total return

-19.2%

20-day SMA

$51.72

200-day SMA

$52.91

3M price change

13.63%

3M total return

13.63%

3Y price change

37.07%

3Y return CAGR

11.08%

3Y total return

37.07%

50-day SMA

$54.41

50-day SMA vs 200-day SMA

50over200

52-week high

$65.98

52-week high date

2025-10-31

52-week low

$44.12

52-week low date

2026-03-30

5Y price change

-42.77%

5Y return CAGR

-10.56%

5Y total return

-42.77%

6M price change

4.14%

6M total return

4.14%

All-time high

$220.20

All-time high date

2021-01-15

All-time low

$11.63

All-time low date

2017-02-15

Average true range (ATR)

$2.54

Average volume

1.5M

Beta (1Y)

2.1

Beta (2Y)

1.84

Beta (5Y)

1.76

Change from 52-week high

-18.05%

Change from 52-week low

22.55%

Change from all-time high

-75.89%

Change from all-time low

356.58%

Change from open

7.15%

Day's gap

-1.96%

Dollar volume

$49M

High price

$54.11

Low price

$50.46

Monthly RSI

49.86

Open price

$50.46

Position in 52-week range

98.9%

Premarket change

-0.89%

Premarket close

$51.47

Premarket price

$51.01

Premarket volume

5.2K

Previous close

$51.47

Price vs 150-day SMA

0.3%

Price vs 20-day SMA

2.67%

Price vs 200-day SMA

0.35%

Price vs 50-day SMA

-2.41%

Relative volume

0.61

RSI

53.05

Sharpe ratio

-0.16

Sharpe ratio (3Y)

0.4

Sharpe ratio (5Y)

0.03

Sortino ratio

-0.13

Sortino ratio (3Y)

0.75

Sortino ratio (5Y)

0.14

Volume

905.5K

Weekly RSI

50.23

YTD price change

1.26%

YTD total return

1.26%

Metric	Value
Float	96.2M
Float percentage	99.47%
Shares change (QoQ)	0.48%
Shares change (YoY)	10.33%
Shares held by insiders	0.53%
Shares held by institutions	78.94%
Shares outstanding	96.7M
Short % of float	17.09%
Short % of shares	17%
Short ratio	11.8 days

Metric

Value

Float

96.2M

Float percentage

99.47%

Shares change (QoQ)

0.48%

Shares change (YoY)

10.33%

Shares held by insiders

0.53%

Shares held by institutions

78.94%

Shares outstanding

96.7M

Short % of float

17.09%

Short % of shares

17%

Short ratio

11.8 days

CRISPR Therapeutics AG (CRSP)

Price

Financial snapshot

Fair-value bridge

Latest news · CRSP

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All CRSP indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on CRSP

Frequently asked questions